Onward Medical N.V. Stock

Equities

ONWD

NL0015000HT4

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Bruxelles 11:35:02 2024-05-31 am EDT 5-day change 1st Jan Change
5.46 EUR +3.02% Intraday chart for Onward Medical N.V. +5.00% +76.13%
Sales 2024 * 2.22M 2.41M Sales 2025 * 9.02M 9.79M Capitalization 189M 205M
Net income 2024 * -35M -37.96M Net income 2025 * -43M -46.63M EV / Sales 2024 * 89.7 x
Net Debt 2024 * 10.53M 11.42M Net Debt 2025 * 82.3M 89.25M EV / Sales 2025 * 30.1 x
P/E ratio 2024 *
-4.9 x
P/E ratio 2025 *
-4.03 x
Employees 99
Yield 2024 *
-
Yield 2025 *
-
Free-Float 81.06%
More Fundamentals * Assessed data
Dynamic Chart
Onward Medical N.V. Announces Publication of Global Up-Lift Pivotal Trial Results in Nature Medicine CI
Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy MT
Onward Medical Raises EUR20 Million Via Private, Public Offering of Shares MT
Onward Medical's Brain-computer Interface Technology Accepted Into US FDA Program MT
Onward Medical's ARC-BCI System Receives Breakthrough Designation MT
Onward Medical Begins Study of ARC-IM Therapy on Hemodynamic Instability Post Spinal Cord Injury MT
Onward Medical N.V. Announces Nature Medicine Publication Highlights Potential for ONWARD ARC Therapy to Improve Mobility After Parkinson's Disease CI
Swiss-designed technology helps Parkinson's patient walk again RE
Onward Medical N.V. Announces First-in-Human Implant of ARC-IM?? Stimulator with Brain-Computer Interface to Restore Arm, Hand, and Finger Function After Spinal Cord Injury CI
Onward Medical N.V. Announces CFO Changes CI
Onward Medical N.V. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Onward Medical Enters Two-year Distribution Deal With Lovell Government Services MT
Onward(R) Launches Partnership with Service-Disabled Veteran-Owned Business to Access U.S. Federal Health Market CI
Onward Medical N.V. Announces First-In-Human Use of Arc-Im(Tm) Lead to Restore Movement and Function After Spinal Cord Injury CI
More news
1 day+3.02%
1 week+5.00%
1 month+14.71%
3 months+9.20%
6 months+56.90%
Current year+76.13%
More quotes
1 week
5.10
Extreme 5.1
5.60
1 month
4.51
Extreme 4.51
6.18
Current year
1.85
Extreme 1.85
6.58
1 year
1.85
Extreme 1.85
6.58
3 years
1.85
Extreme 1.85
13.28
5 years
1.85
Extreme 1.85
13.28
10 years
1.85
Extreme 1.85
13.28
More quotes
Managers TitleAgeSince
Founder 49 13-12-31
Founder - 13-12-31
Chief Executive Officer - 19-12-31
Members of the board TitleAgeSince
Director/Board Member 71 16-12-31
Chairman 67 16-04-18
Director/Board Member 53 16-04-18
More insiders
Date Price Change Volume
24-05-31 5.46 +3.02% 29,533
24-05-30 5.3 +1.92% 53,178
24-05-29 5.2 -.--% 38,188
24-05-28 5.2 -1.14% 75,893
24-05-27 5.26 +1.15% 31,716

Real-time Euronext Bruxelles, May 31, 2024 at 11:35 am EDT

More quotes
Onward Medical N.V. is a medical technology company developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury and movement disabilities.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.46 EUR
Average target price
13.85 EUR
Spread / Average Target
+153.66%
Consensus

Annual profits - Rate of surprise